160 related articles for article (PubMed ID: 21327404)
1. Increased requirement for platelet transfusions concurrent with enhanced bleeding during romiplostim treatment in a patient with thrombocytopenia due to bone marrow failure.
Lotfi R; Moeller P; Schmid M; Schrezenmeier H
Ann Hematol; 2011 Nov; 90(11):1357-9. PubMed ID: 21327404
[No Abstract] [Full Text] [Related]
2. Romiplostim for the management of perioperative thrombocytopenia.
Al-Samkari H; Marshall AL; Goodarzi K; Kuter DJ
Br J Haematol; 2018 Jul; 182(1):106-113. PubMed ID: 29767837
[TBL] [Abstract][Full Text] [Related]
3. Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.
Berthelot-Richer M; Boilard B; Morin A; Bolduc B; Beauregard P; Kotb R
Transfusion; 2012 Apr; 52(4):739-41. PubMed ID: 22082044
[TBL] [Abstract][Full Text] [Related]
4. Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial.
Lee JW; Lee SE; Jung CW; Park S; Keta H; Park SK; Kim JA; Oh IH; Jang JH
Lancet Haematol; 2019 Nov; 6(11):e562-e572. PubMed ID: 31474546
[TBL] [Abstract][Full Text] [Related]
5. [Progression of bone marrow fibrosis with reticulin and collagen hyperplasia during treatment with the thrombopoietin receptor agonist romiplostim in a patient with immune thrombocytopenia].
Kirito K; Komatsu N
Rinsho Ketsueki; 2013 Mar; 54(3):295-9. PubMed ID: 23676646
[TBL] [Abstract][Full Text] [Related]
6. Romiplostim resistance in secondary failure of platelet recovery.
DeRemer DL; Katsanevas K; Bradley A; Awan FT
J Oncol Pharm Pract; 2013 Dec; 19(4):369-72. PubMed ID: 23292974
[TBL] [Abstract][Full Text] [Related]
7. A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia.
Miao J; Leblebjian H; Scullion B; Parnes A
Am J Hematol; 2018 Aug; 93(4):E86-E88. PubMed ID: 29274130
[No Abstract] [Full Text] [Related]
8. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.
Kuter DJ; Bussel JB; Newland A; Baker RI; Lyons RM; Wasser J; Viallard JF; Macik G; Rummel M; Nie K; Jun S
Br J Haematol; 2013 May; 161(3):411-23. PubMed ID: 23432528
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott-Aldrich syndrome.
Khoreva A; Abramova I; Deripapa E; Rodina Y; Roppelt A; Pershin D; Larin S; Voronin K; Maschan A; Novichkova G; Shcherbina A
Br J Haematol; 2021 Jan; 192(2):366-374. PubMed ID: 33131064
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma.
Demeter J; Istenes I; Fodor A; Paksi M; Dombi P; Valasinyószki E; Csomor J; Matolcsy A; Nagy ZG
Pathol Oncol Res; 2011 Mar; 17(1):141-3. PubMed ID: 20628840
[TBL] [Abstract][Full Text] [Related]
11. Romiplostim or standard of care in patients with immune thrombocytopenia.
Kuter DJ; Rummel M; Boccia R; Macik BG; Pabinger I; Selleslag D; Rodeghiero F; Chong BH; Wang X; Berger DP
N Engl J Med; 2010 Nov; 363(20):1889-99. PubMed ID: 21067381
[TBL] [Abstract][Full Text] [Related]
12. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.
Kantarjian HM; Fenaux P; Sekeres MA; Szer J; Platzbecker U; Kuendgen A; Gaidano G; Wiktor-Jedrzejczak W; Carpenter N; Mehta B; Franklin J; Giagounidis A
Lancet Haematol; 2018 Mar; 5(3):e117-e126. PubMed ID: 29396092
[TBL] [Abstract][Full Text] [Related]
14. Romiplostim reverts the thrombocytopenia in dengue hemorrhagic fever.
Rodríguez-Mejorada SM; Rosel-Gómez CG; Rosado-Castro RA; Domingo-Padilla MA; Ruiz-Delgado GJ
Hematol Oncol Stem Cell Ther; 2011; 4(1):48-9. PubMed ID: 21460608
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H
Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773
[No Abstract] [Full Text] [Related]
16. Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).
Gernsheimer TB; George JN; Aledort LM; Tarantino MD; Sunkara U; Matthew Guo D; Nichol JL
J Thromb Haemost; 2010 Jun; 8(6):1372-82. PubMed ID: 20230419
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
Kantarjian H; Fenaux P; Sekeres MA; Becker PS; Boruchov A; Bowen D; Hellstrom-Lindberg E; Larson RA; Lyons RM; Muus P; Shammo J; Siegel R; Hu K; Franklin J; Berger DP
J Clin Oncol; 2010 Jan; 28(3):437-44. PubMed ID: 20008626
[TBL] [Abstract][Full Text] [Related]
18. Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia.
D'Arena G; Cascavilla N
Leuk Lymphoma; 2011 Apr; 52(4):701-4. PubMed ID: 21171868
[No Abstract] [Full Text] [Related]
19. A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia.
Weitz I; Sanz MA; Henry D; Schipperus M; Godeau B; Northridge K; Gleeson M; Danese M; Deuson R
Curr Med Res Opin; 2012 May; 28(5):789-96. PubMed ID: 22494019
[TBL] [Abstract][Full Text] [Related]
20. The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.
Marquínez-Alonso I; Escudero-Vilaplana V; Pernía S; Beléndez Bieler C; Fernández-Llamazares CM; Sanjurjo-Sáez M
J Clin Pharm Ther; 2014 Aug; 39(4):376-82. PubMed ID: 24702274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
